| Financial Year |
March 31 2023 |
| Monetary Funds |
418,758,680.05 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
672,770,919.27 |
| Advances to Suppliers |
129,630,173.24 |
| Other Receivables |
11,595,965.40 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
765,366,395.67 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
21,080,736.28 |
| Total Current Assets |
2,066,776,798.13 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
390,000.00 |
| Long-term Equity Investment |
-- |
| Investment Properties |
7,928,911.20 |
| Fixed Assetes |
440,315,471.91 |
| Under-construction Projects |
16,581,853.52 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
114,328,115.35 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
19,085,318.28 |
| Deferred Income Tax Assets |
36,218,699.27 |
| Other Non-Current Assets |
11,528,670.36 |
| Sub-Total of Non-Current Assets |
1,113,973,594.06 |
| Total Assets |
3,180,750,392.19 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
202,779,103.09 |
| Accounts Payable |
638,877,595.02 |
| Accounts Received In Advance |
2,208,701.56 |
| Employee Compensation Payable |
55,766,896.29 |
| Taxes Payable |
15,770,042.29 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
64,588,382.80 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
27,467,125.07 |
| Other Current Liabilities |
10,778,237.27 |
| Sub-Total of Current Liabilities |
1,030,132,070.51 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
55,374,753.39 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
185,811,841.72 |
| Total Liabilities |
1,215,943,912.23 |
| Paid-In Capital(Or Share Stock) |
334,123,286.00 |
| Capital Surplus |
533,187,451.77 |
| Surplus Reserve |
66,890,050.81 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
838,807,368.57 |
| Minority Stockholder's Interest |
24,761,337.46 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,940,045,142.50 |
| Owner's Equity（Stockholder's Equity） |
1,964,806,479.96 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,180,750,392.19 |
